SCHEMBL10156722

SCHEMBL10156722

CN(CCOS(C)(=O)=O)c1cccc(N=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.37
MTNR1A P48039 13/20 0.34
MTNR1B P49286 13/20 0.34
HTR7 P34969 2/20 0.32
ALDH1A1 P00352 2/20 0.31
TSHR P16473 2/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM4E B2RXH2 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
MMP9 P14780 1/20 0.31
ALOX15 P16050 1/20 0.31
CA12 O43570 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30
PRSS2 P07478 1/20 0.30
CTRC Q99895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401899 0.79 CA12 (0.47) F2MTNR1AMTNR1BALDH1A1TSHR
SCHEMBL283756 0.76 HTR7 (0.48) HTR7ALDH1A1TSHRMAPK1KDM4E
SCHEMBL4550868 0.74 CA1 (0.40) ALDH1A1TSHRKDM4EUSP2LMNA
SCHEMBL1284402 0.73 F2 (0.47) F2ALDH1A1TSHRKDM4EUSP2
SCHEMBL29360890 0.72 ALDH1A1 (0.43) ALDH1A1TSHRTP53MAPK1HIF1A
SCHEMBL5656552 0.70 KDM4E (0.36) ALDH1A1TSHRMAPK1HSD17B10KDM4E
SCHEMBL22804712 0.70 TSHR (0.38) ALDH1A1TSHRKDM4EUSP2LMNA
SCHEMBL11914192 0.69 ALDH1A1 (0.40) ALDH1A1TSHRTP53MAPK1HIF1A
SCHEMBL14313675 0.69 MEN1 (0.41) ALDH1A1KDM4EUSP2LMNA
SCHEMBL10157357 0.69 HTR7 (0.49) HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 F2 4414/4885MTNR1A 4462/4885MTNR1B 4165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.